$397 Million is the total value of Iron Triangle Partners LP's 24 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 58.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EHC | Buy | ENCOMPASS HEALTH CORP | $34,062,000 | +33.0% | 550,000 | +37.5% | 8.58% | -13.4% |
HOLX | New | HOLOGIC INC | $28,500,000 | – | 500,000 | +100.0% | 7.18% | – |
BAX | Buy | BAXTER INTL INC | $28,413,000 | +250.0% | 330,000 | +230.0% | 7.16% | +127.8% |
CRL | Buy | CHARLES RIV LABS INTL INC | $22,666,000 | +79.6% | 130,000 | +30.0% | 5.71% | +16.9% |
CTLT | Buy | CATALENT INC | $20,524,000 | +97.5% | 280,000 | +40.0% | 5.17% | +28.6% |
IQV | New | IQVIA HLDGS INC | $19,519,000 | – | 137,577 | +100.0% | 4.92% | – |
TWST | Buy | TWIST BIOSCIENCE CORP | $19,049,000 | +65.2% | 420,510 | +11.5% | 4.80% | +7.6% |
NVRO | Buy | NEVRO CORP | $17,978,000 | +28.4% | 150,485 | +7.5% | 4.53% | -16.4% |
MOH | Buy | MOLINA HEALTHCARE INC | $17,798,000 | +36.8% | 100,000 | +7.4% | 4.48% | -10.9% |
BMY | Buy | BRISTOL-MYERS SQUIBB CO | $16,917,000 | +21.4% | 287,710 | +15.1% | 4.26% | -21.0% |
INOV | Buy | INOVALON HLDGS INC | $14,119,000 | +85.6% | 733,053 | +60.5% | 3.56% | +20.8% |
GH | Buy | GUARDANT HEALTH INC | $13,427,000 | +382.3% | 165,500 | +313.8% | 3.38% | +213.9% |
MCK | Buy | MCKESSON CORP | $13,041,000 | +48.3% | 85,000 | +30.8% | 3.28% | -3.4% |
AXNX | Buy | AXONICS MODULATION TECHNOLOG | $12,204,000 | +140.1% | 347,591 | +73.8% | 3.07% | +56.3% |
BMY | New | BRISTOL-MYERS SQUIBB COcall | $11,760,000 | – | 200,000 | +100.0% | 2.96% | – |
NVST | New | ENVISTA HOLDINGS CORPORATION | $10,545,000 | – | 500,000 | +100.0% | 2.66% | – |
INSP | New | INSPIRE MED SYS INC | $10,099,000 | – | 116,054 | +100.0% | 2.54% | – |
SGRY | New | SURGERY PARTNERS INC | $7,829,000 | – | 676,652 | +100.0% | 1.97% | – |
RPRX | New | ROYALTY PHARMA PLC | $4,855,000 | – | 100,000 | +100.0% | 1.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
ICON PLC | 10 | Q3 2023 | 11.7% |
BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
NEVRO CORP | 10 | Q1 2022 | 6.7% |
DEXCOM INC | 10 | Q3 2023 | 7.7% |
ABBVIE INC | 9 | Q3 2023 | 8.1% |
ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.